Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
| Autor: | Tsai, D E, Moore, H C F, Hardy, C L, Porter, D L, Loh, E Y, Vaughn, D J, Luger, S, Schuster, S J, Stadtmauer, E A |
|---|---|
| Zdroj: | Bone Marrow Transplantation. 9/1/99, Vol. 24 Issue 5, p521. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|